Covenant Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,454
Closed -$392K 192
2023
Q2
$392K Buy
4,454
+1,043
+31% +$89.8K 0.14% 110
2023
Q1
$275K Sell
3,411
-1,032
-23% -$84.1K 0.11% 146
2022
Q4
$345K Hold
4,443
0.14% 124
2022
Q3
$359K Buy
4,443
+993
+29% +$89.2K 0.18% 109
2022
Q2
$310K Buy
+3,450
New +$350K 0.14% 136
2022
Q1
Sell
-5,601
Closed -$579K 213
2021
Q4
$579K Hold
5,601
0.21% 104
2021
Q3
$702K Hold
5,601
0.28% 79
2021
Q2
$695K Hold
5,601
0.26% 76
2021
Q1
$662K Sell
5,601
-2,934
-34% -$344K 0.26% 83
2020
Q4
$1M Buy
8,535
+2,019
+31% +$222K 0.42% 55
2020
Q3
$677K Buy
6,516
+1,285
+25% +$129K 0.33% 68
2020
Q2
$480K Hold
5,231
0.22% 102
2020
Q1
$472K Buy
5,231
+1,020
+24% +$109K 0.25% 92
2019
Q4
$478K Sell
4,211
-1,496
-26% -$164K 0.22% 104
2019
Q3
$620K Sell
5,707
-4,873
-46% -$508K 0.33% 72
2019
Q2
$1.03M Buy
10,580
+3,657
+53% +$334K 0.55% 35
2019
Q1
$631K Buy
6,923
+33
+0.5% +$2.95K 0.35% 67
2018
Q4
$627K Buy
+6,890
New +$644K 0.3% 27

Other funds holding MDT

Covenant Partners's MDT Position: Q3 2023 in Review

Covenant Partners sold out of Medtronic (MDT) in Q3 2023, closing a stake of 4,454 shares — an estimated $392K sold.

Covenant Partners first reported a position in MDT in Q4 2018 and held it in 18 quarters. The position peaked at $1.03M in Q2 2019. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Covenant Partners reported no remaining Medtronic position as of Q3 2023 after selling out during the quarter.
  • Covenant Partners sold 4,454 Medtronic shares in Q3 2023, an estimated $392K.
  • Covenant Partners first reported a position in Medtronic in Q4 2018 and held it in 18 quarters.
  • Covenant Partners's Medtronic position peaked at $1.03M in Q2 2019.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Covenant Partners's 13F filing for Q3 2023, filed 20 Oct 2023.